Dr. Mark Lee, M.D., Ph.D., N-Power Medicine

N-Power Medicine Raises $72M in Series B Funding to Advance Oncology Clinical Trials Platform

N-Power Medicine, a trailblazer in redefining the clinical trial landscape, has announced a significant milestone with the closure of its Series B funding round, securing $72 million in total funding. Led by the Merck Global Health Innovation Fund, alongside a prominent U.S.-based healthcare investor, this funding infusion marks a pivotal moment for N-Power Medicine as…

Read More

NeOnc Technologies Secures $18.5 Million to Propel Breakthrough Brain Cancer Therapies Through Phase II Trials

NeOnc Technologies Holdings, Inc., a forefront player in clinical-stage biotechnology, has successfully concluded an $18.5 million financing round aimed at advancing its innovative approach to treating brain cancer. This funding milestone includes new equity investment and debt conversions, reflecting a substantial increase in NeOnc’s valuation and reinforcing its commitment to pioneering neurological therapeutics. The financing…

Read More

Bull Moose Tube Welcomes Jim Fink as Chief Operating Officer

Bull Moose Tube Company (“BMT”), a leading manufacturer based in Chesterfield, Missouri and a subsidiary of Caparo Bull Moose (“CBM”), has appointed Jim Fink as its new Chief Operating Officer. With an illustrious career spanning 35 years in pipe and tube engineering and operations, Jim brings extensive expertise to his new role. Jim Fink joins…

Read More

Ephos Secures $8.5M Funding to Transform Quantum Computing with Glass-Based Photonic Chips

Ephos, an innovative leader in glass-based photonic chip technology, has successfully secured $8.5 million in a seed funding round aimed at establishing a groundbreaking research and manufacturing facility in Milan. This initiative, supported by NATO’s Defence Innovation Accelerator (DIANA) and the European Union, marks a pivotal moment in the evolution of quantum and light-based computational…

Read More

Logpresso Raises KRW 16 Billion Series B to Pioneer AI-Driven Cloud Security Operations

Logpresso, a leading cloud-native Security Information and Event Management (SIEM) specialist, has closed a KRW 16 billion (approximately USD 12 million) Series B funding round, signaling a decisive move toward AI-powered security operations. The investment, supported by both existing backer KB Investment and new institutional participants, aims to accelerate the company’s transition to a next-generation…

Read More
Kikleo_team

French Foodtech Star Kikleo Secures €3.5M to Tackle Restaurant Waste Crisis

Paris‑based foodtech startup Kikleo has closed a €3.5 million funding round led by Newfund, with participation from Bpifrance, existing shareholders, and procedural support from Avelana. The fresh capital will drive Kikleo’s expansion across Europe and into the United States, scale its AI platform, and strengthen its on‑the‑ground support teams for restaurant partners. Since its founding…

Read More

Woda Spearheads Telecom Infrastructure Advancement in Safaricom Ethiopia, OneOrder Secures Major Funding for MENA Expansion

In a groundbreaking development within Ethiopia’s telecommunications landscape, Woda CEO Steven Cui proudly heralds the company as the premier local provider of telecom towers to Safaricom Ethiopia. With an unwavering commitment to upholding unparalleled standards of reliability and service quality, Woda exemplifies its dedication to fostering robust connectivity infrastructures. Safaricom Ethiopia’s recent announcement regarding network…

Read More

Revolutionizing Material Science: Maxterial Secures Nearly $8 Million in Series A Funding

In a significant stride towards redefining material science, Maxterial, a pioneering technology company, has successfully concluded its Series A funding round with an impressive raise of nearly $8 million. This achievement not only underscores Maxterial’s growing influence but also highlights its steadfast commitment to revolutionizing traditional industries through cutting-edge advancements in material science. Led by…

Read More

Cellino Secures $25 Million Grant from ARPA-H to Revolutionize Biomanufacturing for Personalized Regenerative Medicine

In a landmark development for the field of regenerative medicine, Cellino Biotech, Inc. has been awarded up to $25 million in funding from the Advanced Research Projects Agency for Health (ARPA-H), a division within the U.S. Department of Health and Human Services. This grant will significantly advance Cellino’s NEBULA, a cutting-edge biomanufacturing technology designed to…

Read More

Viz.ai and ALCMI Forge Strategic Partnership to Advance Lung Cancer Detection

Viz.ai, a trailblazer in AI-driven disease detection and intelligent care coordination, has announced a groundbreaking partnership with the Addario Lung Cancer Medical Institute (ALCMI), a leading international consortium of 25 top lung cancer research institutions. This new collaboration aims to revolutionize early lung cancer detection and enhance patient outcomes through advanced clinical workflows and precision…

Read More